Concepedia

Da‐Liang Ou

DO

Statistics

Publications

39

Citations

1.5K

H-Index

22

Active since

2006

Affiliations

National Taiwan University(Current)

National Taiwan University Hospital

Taipei Medical University

National Health Research Institutes

Institute of Molecular Biology, Academia Sinica

Da‐Liang Ou is an author at National Taiwan University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2006–2025

39

Publications

39

Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma

Da‐Liang Ou, Chiun Hsu, K-L Lin et al. · British Journal of Cancer · 2012 · 201 citations · Full text

, , +17

Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma

Chia‐Lang Hsu, Da‐Liang Ou, Li‐Yuan Bai et al. · Liver Cancer · 2021 · 155 citations · Full text

, , +17

Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages

Da‐Liang Ou, Chia-Wei Chen, Chia‐Lang Hsu et al. · Journal for ImmunoTherapy of Cancer · 2021 · 145 citations · Full text

, , +17

Induction of DNA Damage-Inducible Gene GADD45β Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells

Da‐Liang Ou, Ying‐Chun Shen, Sung‐Liang Yu et al. · Cancer Research · 2010 · 75 citations

, , +17

Role of Twist in head and neck carcinoma with lymph node metastasis.

Da‐Liang Ou, Hsiung‐Fei Chien, Chi‐Long Chen et al. · PubMed · 2008 · 67 citations

, , +15

1–5 of 39